Gabelli Funds’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-465
| Closed | -$261K | – | 1321 |
|
|
2026
Q1 | $261K | Sell |
465
-220
| -32% | -$141K | ﹤0.01% | 1132 |
|
|
2025
Q4 | $463K | Buy |
685
+210
| +44% | +$143K | ﹤0.01% | 1040 |
|
|
2025
Q3 | $303K | Sell |
475
-25
| -5% | -$15.2K | ﹤0.01% | 1106 |
|
|
2025
Q2 | $268K | Hold |
500
| – | – | ﹤0.01% | 1108 |
|
|
2025
Q1 | $210K | Hold |
500
| – | – | ﹤0.01% | 1004 |
|
|
2024
Q4 | $207K | Buy |
500
+25
| +5% | +$11K | ﹤0.01% | 1012 |
|
|
2024
Q3 | $240K | Buy |
475
+25
| +6% | +$12.1K | ﹤0.01% | 990 |
|
|
2024
Q2 | $219K | Hold |
450
| – | – | ﹤0.01% | 981 |
|
|
2024
Q1 | $243K | Hold |
450
| – | – | ﹤0.01% | 970 |
|
|
2023
Q4 | $250K | Buy |
+450
| New | +$211K | ﹤0.01% | 980 |
|
|
2023
Q3 | – | Sell |
-450
| Closed | -$226K | – | 1149 |
|
|
2023
Q2 | $226K | Sell |
450
-100
| -18% | -$47.9K | ﹤0.01% | 1005 |
|
|
2023
Q1 | $275K | Hold |
550
| – | – | ﹤0.01% | 993 |
|
|
2022
Q4 | $224K | Sell |
550
-2,500
| -82% | -$970K | ﹤0.01% | 1060 |
|
|
2022
Q3 | $994K | Hold |
3,050
| – | – | 0.01% | 827 |
|
|
2022
Q2 | $1.07M | Sell |
3,050
-4,400
| -59% | -$1.79M | 0.01% | 832 |
|
|
2022
Q1 | $4.08M | Hold |
7,450
| – | – | 0.03% | 558 |
|
|
2021
Q4 | $4.91M | Hold |
7,450
| – | – | 0.03% | 512 |
|
|
2021
Q3 | $4.63M | Sell |
7,450
-2,100
| -22% | -$1.41M | 0.03% | 524 |
|
|
2021
Q2 | $6.03M | Hold |
9,550
| – | – | 0.04% | 471 |
|
|
2021
Q1 | $4.67M | Sell |
9,550
-750
| -7% | -$376K | 0.03% | 518 |
|
|
2020
Q4 | $5.15M | Sell |
10,300
-2,825
| -22% | -$1.26M | 0.04% | 470 |
|
|
2020
Q3 | $5.16M | Hold |
13,125
| – | – | 0.04% | 433 |
|
|
2020
Q2 | $4.33M | Buy |
13,125
+4,000
| +44% | +$1.16M | 0.04% | 469 |
|
|
2020
Q1 | $2.21M | Sell |
9,125
-4,425
| -33% | -$1.15M | 0.02% | 616 |
|
|
2019
Q4 | $3.54M | Hold |
13,550
| – | – | 0.02% | 603 |
|
|
2019
Q3 | $3.69M | Hold |
13,550
| – | – | 0.02% | 589 |
|
|
2019
Q2 | $3.73M | Hold |
13,550
| – | – | 0.02% | 613 |
|
|
2019
Q1 | $3.03M | Sell |
13,550
-150
| -1% | -$31K | 0.02% | 656 |
|
|
2018
Q4 | $2.55M | Buy |
13,700
+500
| +4% | +$103K | 0.02% | 676 |
|
|
2018
Q3 | $3.3M | Buy |
13,200
+200
| +2% | +$48.5K | 0.02% | 678 |
|
|
2018
Q2 | $2.83M | Buy |
13,000
+1,100
| +9% | +$227K | 0.02% | 711 |
|
|
2018
Q1 | $2.28M | Hold |
11,900
| – | – | 0.01% | 749 |
|
|
2017
Q4 | $1.86M | Sell |
11,900
-100
| -0.8% | -$15.7K | 0.01% | 796 |
|
|
2017
Q3 | $1.87M | Hold |
12,000
| – | – | 0.01% | 797 |
|
|
2017
Q2 | $1.94M | Buy |
+12,000
| New | +$1.95M | 0.01% | 787 |
|
Other funds holding IDXX
Gabelli Funds's IDXX Position: Q2 2026 in Review
Gabelli Funds sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 465 shares — an estimated $261K sold.
Gabelli Funds first reported a position in IDXX in Q2 2017 and held it in 35 quarters. The position peaked at $6.03M in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Gabelli Funds reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- Gabelli Funds sold 465 Idexx Laboratories shares in Q2 2026, an estimated $261K.
- Gabelli Funds first reported a position in Idexx Laboratories in Q2 2017 and held it in 35 quarters.
- Gabelli Funds's Idexx Laboratories position peaked at $6.03M in Q2 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.